Krilogy Financial’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.22M | Buy |
6,879
+1,814
| +36% | +$1.84M | 0.2% | 84 |
|
|
2025
Q4 | $5.38M | Buy |
5,065
+789
| +18% | +$754K | 0.18% | 87 |
|
|
2025
Q3 | $3.96M | Buy |
+4,276
| New | +$3.18M | 0.15% | 115 |
|
|
2023
Q2 | – | Sell |
-2,919
| Closed | -$1M | – | 311 |
|
|
2023
Q1 | $1M | Sell |
2,919
-45
| -2% | -$15.2K | 0.08% | 182 |
|
|
2022
Q4 | $1.08M | Buy |
2,964
+629
| +27% | +$223K | 0.1% | 157 |
|
|
2022
Q3 | $755K | Buy |
2,335
+4
| +0.2% | +$1.27K | 0.09% | 151 |
|
|
2022
Q2 | $756K | Sell |
2,331
-306
| -12% | -$91.9K | 0.09% | 155 |
|
|
2022
Q1 | $755K | Buy |
2,637
+696
| +36% | +$179K | 0.08% | 155 |
|
|
2021
Q4 | $536K | Sell |
1,941
-237
| -11% | -$60.1K | 0.05% | 183 |
|
|
2021
Q3 | $503K | Sell |
2,178
-177
| -8% | -$43.7K | 0.05% | 191 |
|
|
2021
Q2 | $540K | Sell |
2,355
-185
| -7% | -$37.2K | 0.05% | 173 |
|
|
2021
Q1 | $474K | Buy |
2,540
+723
| +40% | +$141K | 0.05% | 179 |
|
|
2020
Q4 | $307K | Sell |
1,817
-116
| -6% | -$17.3K | 0.04% | 211 |
|
|
2020
Q3 | $286K | Buy |
1,933
+235
| +14% | +$36.4K | 0.04% | 199 |
|
|
2020
Q2 | $279K | Buy |
+1,698
| New | +$261K | 0.04% | 184 |
|
|
2018
Q4 | – | Sell |
-668
| Closed | -$72K | – | 438 |
|
|
2018
Q3 | $72K | Buy |
+668
| New | +$66.8K | 0.02% | 265 |
|
|
2018
Q2 | – | Sell |
-723
| Closed | -$56K | – | 420 |
|
|
2018
Q1 | $56K | Sell |
723
-3
| -0.4% | -$242 | 0.01% | 309 |
|
|
2017
Q4 | $61K | Sell |
726
-302
| -29% | -$25.7K | 0.01% | 294 |
|
|
2017
Q3 | $88K | Buy |
1,028
+128
| +14% | +$10.5K | 0.02% | 270 |
|
|
2017
Q2 | $74K | Buy |
900
+5
| +0.6% | +$408 | 0.02% | 257 |
|
|
2017
Q1 | $66K | Hold |
895
| – | – | 0.02% | 257 |
|
|
2016
Q4 | $66K | Buy |
895
+3
| +0.3% | +$223 | 0.02% | 257 |
|
|
2016
Q3 | $72K | Sell |
892
-147
| -14% | -$11.8K | 0.02% | 250 |
|
|
2016
Q2 | $82K | Buy |
1,039
+255
| +33% | +$19.2K | 0.03% | 226 |
|
|
2016
Q1 | $56K | Buy |
784
+2
| +0.3% | +$151 | 0.02% | 252 |
|
|
2015
Q4 | $66K | Buy |
782
+3
| +0.4% | +$249 | 0.06% | 114 |
|
|
2015
Q3 | $65K | Buy |
+779
| New | +$65.8K | 0.03% | 173 |
|
Other funds holding LLY
VCM
VPM
Krilogy Financial's LLY Position: Q1 2026 in Review
Krilogy Financial increased its Eli Lilly (LLY) stake by 36% in Q1 2026, buying an estimated $1.84M and bringing the position to 6,879 shares worth $6.22M. The position accounts for 0.2% of the portfolio, ranked #84.
Krilogy Financial first reported a position in LLY in Q3 2015 and has held it in 27 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Krilogy Financial held 6,879 shares of Eli Lilly worth $6.22M as of Q1 2026.
- Krilogy Financial bought 1,814 Eli Lilly shares in Q1 2026, an estimated $1.84M.
- Eli Lilly made up 0.2% of Krilogy Financial's portfolio in Q1 2026, its #84 holding.
- Krilogy Financial first reported a position in Eli Lilly in Q3 2015 and has held it in 27 quarters since.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Krilogy Financial's 13F filing for Q1 2026, filed 17 Apr 2026.